$1.47
-0.11-6.96%
Last update: Nov 10, 4:00 PM
BioLine Rx Ltd
BLRXNASDAQ
The average analyst price target for BioLine Rx is $19, 1087.5% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $12 to $26. The latest change came on May 30, 2025, when Jones Trading upgraded BioLine Rx from Hold to Buy with a $12 price target.
Price Target Range — 7 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
